SELLBYVILLE, Del., Dec. 15, 2017
/PRNewswire-iReach/ -- The Industry growth report "Cancer Gene
Therapy Market By Type [Gene Induced Immunotherapy (Cytokine
Gene Delivery, Tumor Antigen Gene Delivery), Oncolytic Virotherapy
(Adenoviruses, Lentiviruses, Retrovirus, Adeno Associated Virus,
Herpes Simplex Virus, Alphavirus, Vaccinia Virus, Simian Virus),
Gene Transfer/Gene Replacement (Naked/Plasmid Vectors,
Electroporation, Sonoporation, Magnetofection, Gene Gun)], Industry Analysis Report, Regional
Outlook (U.S., Canada, UK,
Germany, China, Japan,
Mexico, Brazil, South
Africa, Saudi Arabia),
Application Potential, Price Trends, Competitive Market Share &
Forecast, 2016 – 2024" by Global Market Insights, Inc.
forecast Cancer Biological Therapy Market share is anticipated to
surpass $4.3 billion by 2024.
Globally, rising cancer prevalence will increase demand for gene
therapy as the effective personalized treatment choice.
According to WHO, cancer incidence is projected to rise by 50% to
reach 15 million by the end of this decade. This alarming increase
in number of patients necessitates this as a potential treatment
approach addressing the growing global burden of the disease.
Increased adoption of emerging genomic technologies such as NGS
and high density micro array coupled with favourable government
initiatives will fuel global cancer gene therapy market size. For
instance, CDC supports nationwide screening programs for control of
breast, cervical and colorectal cancer among low-income women with
little or no health insurance. However, high cost of development
lack of reimbursement and regulatory processes will restrain
industry growth.
Request for a sample of this research report @
https://www.gminsights.com/request-sample/detail/763
Growing number of clinical trials and availability of wide range
of genes and vectors used in these trials will enable emergence of
new treatment modalities to help make cancer a manageable disease.
By the end of 2012, the number of clinical trials crossed 1,800
worldwide.
Adenoviral vector remains as the most common oncology
application due to its competent nuclear mechanism and low
pathogenicity. It is widely used in replacement approaches, suicide
and gene-based immunotherapy, and syndicate with chemotherapy and
is anticipated to grow at 20% CAGR.
Retroviral vector-mediated gene transfer dominated the
development by enabling the conversion of single stranded RNA into
a double stranded DNA molecule, which steadily integrates into the
target cell genome. These vectors are used to permanently modify
the host cell nuclear genome and will register a robust growth of
over 20%.
U.S. led the industry owing to increased R&D funding and
other government initiatives. Growing number of biotech companies
are engaging in R&D and clinical trials of gene therapy
products. Increased demand for DNA vaccines and increasing interest
of venture capitalists to invest in commercialization of gene
therapies will trigger industry expansion.
China cancer gene therapy
market size attributed to over 35% APAC revenue in 2015. With the
launch of Gendicine and increasing healthcare expenditure and
robust R&D facilities will enable industry growth.
Browse key industry insights spread across 105 pages with 125
market data tables & 6 figures & charts from the report,
"Cancer Gene Therapy Market" in detail along with the table
of contents:
https://www.gminsights.com/industry-analysis/cancer-gene-therapy-market
U.S. cancer gene therapy market share accounted for over 95%
regional revenue in 2015, with market size of USD 235 million and a forecast to grow at 20.9%
CAGR.
UK was over USD 92.0 million in
2015, and will grow at 20.8% CAGR owing to increasing incidence of
cancer and adoption of advanced treatment methods.
China market size was valued at
USD 99.6 million in 2015 and growth
expectations of 21% CAGR over the forecast years.
Key players include SiBiono, Altor Bioscience Corporation,
Shanghai Sunway Biotech company limited, Amgen, BioCancell,
OncoGeneX, Aduro Biotech, GlobeImmune, Inc., New Link Genetics.,
ZioPharm Oncology, MolMed, GENELUX, Gradalis, MultiVir.
Make an inquiry for purchasing this report @
https://www.gminsights.com/inquiry-before-buying/763
The industry is highly fragmented and is dominated by several
small biotech firms collectively accounting for over 80% of cancer
gene therapy market pipeline. Major growth strategies adopted by
these small firms include, technology transfer, licensing and
commercialization deals, strategic collaborations and mergers and
acquisitions to retain their industry position.
Browse Related Reports:
Lung Cancer Diagnostics Market Size 2017 – 2024
Lung Cancer Diagnostics Market share is projected to experience
significant growth from 2017 to 2024. Lung cancer diagnostics
market size should witness significant growth due to increased
prevalence of smoking and exposure to second hand smoke,
influencing the occurrence rate of lung malignancies.
https://www.gminsights.com/industry-analysis/lung-cancer-diagnostics-market
Cancer Profiling Market Size 2017 – 2024
Cancer Profiling Market share is projected to experience
significant growth from 2017 to 2024. Rising prevalence of cancer
worldwide and huge funding available for oncology research are the
major factors driving global cancer profiling market growth.
https://www.gminsights.com/industry-analysis/cancer-profiling-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research
and consulting service provider; offering syndicated and custom
research reports along with growth consulting services. Our
business intelligence and industry research reports offer clients
with penetrative insights and actionable market data specially
designed and presented to aid strategic decision making. These
exhaustive reports are designed via a proprietary research
methodology and are available for key industries such as chemicals,
advanced materials, technology, renewable energy and
biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://www.gminsights.com/blogs
Connect with
us: Facebook | Google+ | LinkedIn | Twitter
Media Contact: Arun Hegde,
Global Market Insights, Inc., +13028467766,
sales@gminsights.com
News distributed by PR Newswire iReach:
https://ireach.prnewswire.com
SOURCE Global Market Insights